AMN Healthcare AMN Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $67.17M-24.8% | $89.31M-17.5% | $108.27M-21.5% | $137.87M-44.1% | ||
| $382.56M-12.6% | $437.82M-29.8% | $623.49M-7.7% | $675.65M-14.4% | ||
| $545.38M-8.3% | $594.92M-29.3% | $841.69M-23.0% | $1.09B-18.9% | ||
| $136.36M-26.8% | $186.27M-2.7% | $191.39M+28.2% | $149.28M+17.4% | ||
| $755.81M-15.8% | $897.46M-19.3% | $1.11B+18.8% | $935.36M+4.8% | ||
| $283.53M-25.7% | $381.36M-19.6% | $474.13M-0.6% | $476.83M-7.3% | ||
| $2.09B-13.3% | $2.42B-17.4% | $2.92B+1.2% | $2.89B-7.8% | ||
| $161.97M-12.1% | $184.31M-46.4% | $343.85M-27.8% | $476.45M+12.0% | ||
| $9.5M-5.2% | $10.01M-11.4% | $11.3M-4.4% | $11.83M-25.9% | ||
| $577.61M+5.8% | $545.79M-16.8% | $656.12M-23.5% | $857.93M-11.5% | ||
| $742.05M-12.3% | $845.87M+0.1% | $844.69M+0.1% | $843.51M+0.1% | ||
| $1.45B-15.0% | $1.71B-18.3% | $2.09B+13.5% | $1.84B-6.4% | ||
| 200M+39,348% | 507K+0.6% | 504K+0.6% | 501K+0.6% | ||
| $1.21B-7.3% | $1.3B-10.1% | $1.45B+17.0% | $1.24B+55.7% | ||
| $642.11M-9.1% | $706.62M-15.0% | $831.26M-20.3% | $1.04B-10.2% | ||
| $2.09B-13.3% | $2.42B-17.4% | $2.92B+1.2% | $2.89B-7.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AMN Healthcare's total assets?
- AMN Healthcare (AMN) holds $2.6B in total assets, up 8.7% year over year.
- How much debt does AMN Healthcare have?
- AMN Healthcare carries $776.9M in total debt against $712.8M of shareholders' equity, a debt-to-equity ratio of 1.09.
- How much cash does AMN Healthcare have?
- AMN Healthcare holds $595.0M in cash and equivalents.
- Can AMN Healthcare cover its short-term obligations?
- Its current ratio is 1.09 — current assets exceed current liabilities.
- Where does AMN Healthcare's balance sheet data come from?
- Every line is extracted from AMN Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
